The solvent chosen for the manufacturing of electrospun polycaprolactone scaffolds influences cell behavior of lung cancer cells

被引:0
作者
Emma Polonio-Alcalá
Enric Casanova-Batlle
Teresa Puig
Joaquim Ciurana
机构
[1] University of Girona,Product, Process and Production Engineering Research Group (GREP), Department of Mechanical Engineering and Industrial Construction
[2] University of Girona,New Therapeutic Targets Laboratory (TargetsLab)
来源
Scientific Reports | / 12卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The development of a trustworthy in vitro lung cancer model is essential to better understand the illness, find novel biomarkers, and establish new treatments. Polycaprolactone (PCL) electrospun nanofibers are a cost-effective and ECM-like approach for 3D cell culture. However, the solvent used to prepare the polymer solution has a significant impact on the fiber morphology and, consequently, on the cell behavior. Hence, the present study evaluated the effect of the solvent employed in the manufacturing on the physical properties of 15%-PCL electrospun scaffolds and consequently, on cell behavior of NCI-H1975 lung adenocarcinoma cells. Five solvents mixtures (acetic acid, acetic acid-formic acid (3:1, v/v), acetone, chloroform-ethanol (7:3, v/v), and chloroform-dichloromethane (7:3, v/v)) were tested. The highest cell viability (x¯\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline{x }$$\end{document} = 33.4%) was found for cells cultured on chloroform-ethanol (7:3) PCL scaffolds. Chloroform-dichloromethane (7:3) PCL scaffolds exhibited a roughness that enhanced the quality of electrospun filament, in terms of cell viability. Our findings highlighted the influence of the solvent on fiber morphology and protein adsorption capacity of nanofilaments. Consequently, these features directly affected cell attachment, morphology, and viability.
引用
收藏
相关论文
共 317 条
[1]  
Bray F(2018)Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J. Clin. 68 394-424
[2]  
Ferlay J(2020)Molecular profiling of non-small cell lung cancer PLoS One 15 e0236580-24
[3]  
Soerjomataram I(2020)Epidemiology, etiology, and prevention Clin. Chest Med. 41 1-1260
[4]  
Siegel RL(2015)On behalf of the WHO panel, the 2015 World Health Organization classification of lung tumors J. Thorac. Oncol. 10 1243-2139
[5]  
Torre LA(2004)Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N. Engl. J. Med. 350 2129-141
[6]  
Jemal A(2018)Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer Mol Cancer. 17 38-41
[7]  
Forsythe ML(2020)3D tumor models and their use for the testing of immunotherapies Front. Immunol. 11 603640-223
[8]  
Alwithenani A(2017)Long-range self-organization of cytoskeletal myosin II filament stacks Nat. Cell Biol. 19 133-893
[9]  
Bethune D(2014)3D cell culture systems modeling tumor growth determinants in cancer target discovery Adv. Drug Deliv. Rev. 69–70 29-9453
[10]  
Castonguay M(1996)Nanometre diameter fibres of polymer, produced by electrospinning Nanotechnology 7 216-2905